RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Harvoni
NS5A inhibitor + NS5B polymerase inhibitor
Constituent drugs (2)
Ledipasvir
Loading structure...
3D not available
Sofosbuvir
Loading structure...
Loading 3D structure...
PubChem CID 45375808
Chemical Identifiers
ClinicalTrials.gov
PubMed
Clinical Development by Virus
1
Hepatitis C virus
HCV
Target: Viral NS5A + NS5B
Approved (other)
Preclinical
Phase 2
positive
Phase 3
positive
Approved
Japan
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PMDA approved 2015/7/3
fixed-dose combination of Ledipasvir, Sofosbuvir.